These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28068655)

  • 1. Carotid Intima-Media Thickness in Children Treated with Growth Hormone: A Follow-Up Study over Three Years.
    Rothermel J; Knop C; Lass N; Toschke C; Wunsch R; Reinehr T
    Horm Res Paediatr; 2017; 87(2):73-80. PubMed ID: 28068655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carotid intima-media thickness in children treated with growth hormone.
    Knop C; Wolters B; Lass N; Wunsch R; Reinehr T
    J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):985-91. PubMed ID: 25210755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone and the risk of atherosclerosis in growth hormone-deficient children.
    Binay C; Simsek E; Yıldırım A; Kosger P; Demiral M; Kılıç Z
    Growth Horm IGF Res; 2015 Dec; 25(6):294-7. PubMed ID: 26296621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone.
    Saygılı S; Kocaağa M; Kaya G; Şükür M; Baş F; Poyrazoğlu Ş; Bundak R; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2023 Feb; 15(1):69-80. PubMed ID: 36416456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GH response to provocation and circulating IGF-I and IGF-binding protein-3 concentrations, the IGF-I generation test and clinical response to GH therapy in children with beta-thalassaemia.
    Soliman AT; El Banna N; Ansari BM
    Eur J Endocrinol; 1998 Apr; 138(4):394-400. PubMed ID: 9578506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of one-year growth hormone therapy on body composition and cardio-metabolic risk in Indian children with growth hormone deficiency.
    Khadilkar V; Ekbote V; Kajale N; Khadilkar A; Chiplonkar S; Kinare A
    Endocr Res; 2014; 39(2):73-8. PubMed ID: 24066645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3.
    Juul A; Skakkebaek NE
    J Pediatr; 1997 Feb; 130(2):197-204. PubMed ID: 9042120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the peripheral sensitivity to growth hormone in adults with GH deficiency.
    Aimaretti G; Fanciulli G; Bellone S; Maccario M; Arvat E; Delitala G; Camanni F; Ghigo E
    Eur J Endocrinol; 2001 Sep; 145(3):267-72. PubMed ID: 11517006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of IGF-I, IGFBP-3, and IGFBP-2 measurements during GH treatment of GH-deficient and non-GH-deficient children and adolescents.
    Ranke MB; Schweizer R; Elmlinger MW; Weber K; Binder G; Schwarze CP; Wollmann HA
    Horm Res; 2001; 55(3):115-24. PubMed ID: 11549872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-I and IGF-binding protein-3 measurements on filter paper blood spots in children and adolescents on GH treatment: use in monitoring and as markers of growth performance.
    Das U; Whatmore AJ; Khosravi J; Wales JK; Butler G; Kibirige MS; Diamandi A; Jones J; Patel L; Hall CM; Price DA; Clayton PE
    Eur J Endocrinol; 2003 Sep; 149(3):179-85. PubMed ID: 12943519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the ligand immunofunctional assay for human insulin-like growth factor ((IGF) binding protein-3 (IGFBP-3) to analyze IGFBP-3 proteolysis and igf-i bioavailability in healthy adults, GH-deficient and acromegalic patients, and diabetics.
    Lassarre C; Duron F; Binoux M
    J Clin Endocrinol Metab; 2001 May; 86(5):1942-52. PubMed ID: 11344189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
    Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic efficiency of serum IGF-I, IGF-binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and urinary GH measurements in the diagnosis of adult GH deficiency: importance of an appropriate reference population.
    Granada ML; Murillo J; Lucas A; Salinas I; Llopis MA; Castells I; Foz M; Sanmartí A
    Eur J Endocrinol; 2000 Mar; 142(3):243-53. PubMed ID: 10700718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum leptin response to the acute and chronic administration of growth hormone (GH) to elderly subjects with GH deficiency.
    Gill MS; Toogood AA; Jones J; Clayton PE; Shalet SM
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1288-95. PubMed ID: 10199769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
    Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.